You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

microvascular invasion

Showing 1 - 25 of 1,463
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Sintilimab
  • Transarterial Chemoembolization (TACE)
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Hepatocellular Carcinoma Trial in Shanghai (Stereotactic radiotherapy)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Stereotactic radiotherapy
  • Shanghai, Shanghai, China
    Second Military Medical University
Aug 14, 2021

Hepatocellular Carcinoma, Recurrence Trial in Guangzhou (Sorafenib)

Terminated
  • Hepatocellular Carcinoma
  • Recurrence
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 9, 2020

Hepatocellular Carcinoma, Malignant Tumor Trial in Beijing (TACE plus autologous Tcm immunotherapy, TACE)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Malignant Neoplasm
  • TACE plus autologous Tcm immunotherapy
  • TACE
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Jun 3, 2020

Hepatocellular Carcinoma Trial in Nanning (procedure, drug, other)

Recruiting
  • Hepatocellular Carcinoma
  • TACE
  • +3 more
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 7, 2020

Artificial Intelligence and Hepatocellular Carcinoma

Active, not recruiting
  • HCC
  • CT Scan Radiomics Features Extraction
  • Rozzano, Lombardy, Italy
    IRCCS Istituto Clinico Humanitas
Dec 1, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib)

Unknown status
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    SUN YAT-SEN University Cancer Center
Aug 10, 2019

Chromosomal Abnormalities asPredictor of Staging and Prognosis

Enrolling by invitation
  • Hepatocellular Carcinoma
  • Liver resection method
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital，College of Medicine，Zhejiang Unive
May 16, 2022

Hepatocellular Cancer Trial in Clichy (IRM with a 5-minute- additional sequence to measure FRM)

Completed
  • Hepatocellular Cancer
  • IRM with a 5-minute- additional sequence to measure FRM
  • Clichy, France
    Valérie Vilgrain
Jun 20, 2022

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 10, 2022

Vascular Invasion Signatures in cfDNA Support Re-staging of

Completed
  • Carcinoma, Hepatocellular
  • +2 more
  • Liver resection
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022

Resectable Hepatocellular Carcinoma Trial (Tislelizumab, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Mar 29, 2023

Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
  • +4 more
  • Guangzhou, Guangdong, China
    SUN Yat-sen University Cancer Center
Sep 11, 2023

Hepatocellular Carcinoma Trial in Beijing (Donafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Dec 2, 2021

Hepatocellular Carcinoma Trial (circulating tumor DNA dosage)

Not yet recruiting
  • Hepatocellular Carcinoma
  • circulating tumor DNA dosage
  • (no location specified)
May 16, 2022

Liver Transplantation in Incidental

Recruiting
  • Adult Combined Hepatocellular-Cholangiocarcinoma
  • liver transplantation
  • Istanbul, Turkey
    Group Florence Nightingale Hospitals
Feb 26, 2022

Hepatocellular Carcinoma, Radiotherapy, Apatinib Trial in Guangzhou (Radiotherapy, Apatinib, Radiotherapy+apatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Radiotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Nov 4, 2018

Microvascular Flow and Reactivity in Patients Presenting in

Completed
  • Coronavirus Infection
  • +2 more
  • evaluation of skin microvascular flow and reactivity
  • Rio de Janeiro, Brazil
    National Institute of Cardiology
Jan 11, 2022

Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • San Francisco, California
  • +8 more
Jul 19, 2022

AFP Model and Liver Transplantation.

Completed
  • Liver Carcinoma
  • Liver Transplant Disorder
  • Liver transplantation
  • Pilar, Buenos Aires, Argentina
  • +1 more
Dec 14, 2018

Liver Resection Trial in Guangzhou (Radiomics and Watson artificial intelligence)

Recruiting
  • Liver Resection
  • Radiomics and Watson artificial intelligence
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 13, 2022

HepatoCellular Carcinoma Trial in Nanning (Postoperative radiotherapy, Postoperative TACE)

Recruiting
  • HepatoCellular Carcinoma
  • Postoperative radiotherapy
  • Postoperative TACE
  • Nanning, Guangxi, China
    TaoBai
Jul 8, 2018

ABSOLOK™ Clip System-RFP-2021-01 in Open Liver Resection

Not yet recruiting
  • Bile Leak
  • ABSOLOK™ Clip System
  • Roma, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 20, 2023

hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Liver Transplant; Complications
  • liver transplant
  • +2 more
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 21, 2021